Trials / Conditions / Renal Pelvic Carcinoma

Renal Pelvic Carcinoma

3 registered clinical trials studyying Renal Pelvic Carcinoma — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Nephron-sparing Treatment of Tislelizumab + Nab-Paclitaxel for Renal Pelvic Cancer NCT07233252	Tianjin Medical University Second Hospital	Phase 2
Recruiting	Postoperative Adjuvant Immunotherapy Combined with Radiotherapy Versus Surgery Alone in Locally Advanced UTUC NCT06598761	Peking University First Hospital	—
Recruiting	Radiotherapy Combined with Systemic Therapy Versus Systemic Therapy for Oligometastatic UTUCs NCT06652022	Peking University First Hospital	N/A